41. NEJM -- Efficacy Of Lenalidomide In Myelodysplastic Syndromes Original Article from The New England Journal of Medicine Efficacy of Lenalidomidein myelodysplastic syndromes. http://content.nejm.org/cgi/content/short/352/6/549

HOME SEARCH CURRENT ISSUE PAST ISSUES ... HELP Please sign in for full text and personal services Previous Volume 352:549-557 February 10, 2005 Number 6 Next Efficacy of Lenalidomide in Myelodysplastic Syndromes Alan List, M.D., Sandy Kurtin, C.N.P., M.S., Denise J. Roe, Dr.P.H., Andrew Buresh, M.D., Daruka Mahadevan, M.D., Ph.D., Deborah Fuchs, M.D., Lisa Rimsza, M.D., Ruth Heaton, B.S., Robert Knight, M.D., and Jerome B. Zeldis, M.D. Full Text PDF PDA Full Text PowerPoint Slide Set ... PubMed Citation ABSTRACT Background Ineffective erythropoiesis is the hallmark of myelodysplastic syndromes. Management of the anemia caused by ineffective erythropoiesis is difficult. In patients with myelodysplastic syndromes and symptomatic anemia, we evaluated the safety and hematologic activity of lenalidomide, a novel analogue of thalidomide. Methods Forty-three patients with transfusion-dependent or symptomatic anemia received lenalidomide at doses of 25 or 10 mg per day or of 10 mg per day for 21 days of every 28-day cycle. All patients either had had no response to recombinant erythropoietin or had a high endogenous erythropoietin level with a low probability of benefit from such therapy. The response to treatment was

42. NEJM -- Myelodysplastic Syndromes -- Coping With Ineffective Hematopoiesis Perspective from The New England Journal of Medicine myelodysplastic syndromes Coping with Ineffective Hematopoiesis. http://content.nejm.org/cgi/content/short/352/6/536

HOME SEARCH CURRENT ISSUE PAST ISSUES ... HELP Please sign in for full text and personal services Previous Volume 352:536-538 February 10, 2005 Number 6 Next Mario Cazzola, M.D., and Luca Malcovati, M.D. Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings. Full Text PDF PDA Full Text Letters ... PubMed Citation One of the most challenging problems in hematology is the heterogeneous group of disorders that were formally defined as myelodysplastic Group in 1982. This set of disorders includes idiopathic conditions as well as the secondary or therapy-related forms that develop after exposure to alkylating agents, radiation, or both. Idiopathic myelodysplastic syndromes occur mainly in older persons: the incidence of these syndromes is about 5 per 100,000 persons per year in the general population, but it increases to 20 to 50 per 100,000 persons per year after 60 years of age. Approximately 15,000 new cases are Full Text of this Article Related Letters: Treatment of Myelodysplastic Syndromes Chng W. J., Stadler M., Ganser A., List A. F., Cazzola M., Malcovati L.

43. Myelodysplastic Syndromes (MDS) 238.7 Myelodysplastic syndrome REFERENCES; Hoffman R, Benz EJ Jr, Shattil S, etal, eds Hematology Basic Principles and Practice. 3rd Ed. New York, http://www.5mcc.com/Assets/SUMMARY/TP0609.html

Myelodysplastic syndromes (MDS) DESCRIPTION: A heterogeneous group of acquired hematopoietic stem cell disorders, characterized by cytologic dysplasia in the bone marrow and blood and by various combinations of anemia, neutropenia, and thrombocytopenia There is a natural progression of disease between categories as cellular maturation becomes more arrested and blast cells accumulate. There is a great deal of overlap between arbitrary diagnostic subgroups. Refractory cytopenia - same as RA but with leukopenia or thrombocytopenia without anemia Refractory cytopenia with multi-lineage dysplasia (RCMD) - marked trilineage dysplasia but without excess of blasts Acute MDS with sclerosis - RAEB with marked myelosclerosis Therapy-related (t-MDS) - seen 3-7 years after treatment with alkylating agents and/or radiation therapy. Evolves to acute myeloid leukemia (AML) over about 6 months. System(s) affected: Hemic/Lymphatic/Immunologic Genetics: Most are clearly clonal neoplasms by cytogenetics, G6PD isoenzyme analysis, or RFLP analysis. Mutations in RAS oncogene have been reported. Incidence/Prevalence in USA: Apparent increased incidence (1-2/100,000/year) in recent years may be due to more accurate diagnosis

44. Myelodysplastic Syndromes - CancerIndex These myelodysplastic syndromes can occur in all age groups but are more common myelodysplastic syndromes may develop spontaneously or be secondary to http://www.cancerindex.org/clinks4d.htm

Home Site Map Cancer Types Treatments ... About Myelodysplastic Syndromes Home Cancer Types Hematological Myelodysplastic Syndromes Myelodysplastic Syndromes (6 links) Myelodysplastic syndromes, sometimes called "pre-leukaemia" are a group of diseases in which the bone marrow does not produce enough normal blood cells. Common symptoms are anaemia, bleeding, easy bruisability, and fatigue. These Myelodysplastic syndromes can occur in all age groups but are more common in people aged over 60. Myelodysplastic syndromes may develop spontaneously or be secondary to treatment with chemotherapy / radiotherapy. There is an association with Myelodysplastic syndromes and acute myeloid leukaemia. Patient's information for Myelodysplastic Syndromes (CancerNet) Information about the disease, staging, and treatment overviews. It is reviewed each month by a panel of medical experts. Myelodysplastic Syndrome - Booklet (Leukemia and Lymphoma Society, USA) Myelodysplastic Syndromes (Leukemia Research Fund , UK) on-line booklet Myelodysplastic Syndromes Foundation The Foundation was established by a group of international physicians and researchers to provide an ongoing exchange of information about MDS. The web site includes information for patients, health professionals and researchers.

45. Introduction: Myelodysplastic Syndromes - WrongDiagnosis.com Introduction to myelodysplastic syndromes as a medical condition includingsymptoms, diagnosis, misdiagnosis, treatment, prevention, and prognosis. http://www.wrongdiagnosis.com/m/myelodysplastic_syndromes/intro.htm

Home Symptoms Diseases Risks ... Diseases Search our medical database Subscribe to our free Newsletter sample Send this page to a friend Condition Lists By Organ By Symptom By Class By Prevalence ... List A-Z Current chapter: Myelodysplastic syndromes Next sections Basic Summary for Myelodysplastic syndromes Prevalence and Incidence of Myelodysplastic syndromes Prognosis of Myelodysplastic syndromes Causes of Myelodysplastic syndromes ... Misdiagnosis of Underlying Causes of Myelodysplastic syndromes Next chapters: Defibrination syndrome Chromomycosis Phaeohyphomycosis Transsexualism ... Feedback Introduction: Myelodysplastic syndromes Myelodysplastic syndromes: Various bone marrow disorders Causes of Myelodysplastic syndromes: Research more detailed information about the causes of Myelodysplastic syndromes , other possibly hidden causes of Myelodysplastic syndromes , or other general information about Myelodysplastic syndromes Statistics and Myelodysplastic syndromes: Various sources and calculations are available in statistics about Myelodysplastic syndromes prevalence and incidence statistics for Myelodysplastic syndromes , and you can also research other medical statistics in our statistics center Contents for Myelodysplastic syndromes: Basic Summary for Myelodysplastic syndromes Prevalence and Incidence of Myelodysplastic syndromes Prognosis of Myelodysplastic syndromes Causes of Myelodysplastic syndromes ... Diseases Did we miss something? Please provide

46. Protocols For Myelodysplastic Syndromes - UMass Medical School for the Treatment of myelodysplastic syndromes and Acute Myeloid Leukemia . of patients with intermediate and high risk myelodysplastic syndromes. http://www.umassmed.edu/hema_oncology/mdscenter/mdsprotocols.cfm

directory contacts index this section only Hematology/Oncology Home MDS Center Research Protocols ... MDSCenter P.I. Raza P.I. Raza P.I. Raza Oral iron chelation (ICL670) in patients with low or Intermediate-1 risk myelodysplastic syndromes A pilot study to test the efficacy of curcumin and gingerol in patients with myelodysplastic syndromes P.I. Raza INTRANET top print This is an official Page/Publication of the University of Massachusetts Worcester Campus Hematology/Oncology 55 Lake Avenue North Worcester, MA 01655 Questions or Comments? Email: murtaza.mehdi@umassmed.edu

47. ACOR Leukemia Links: Resources For Myelodysplasia & Myeloproliferative Disorders Resources for Myelodysplasia or myelodysplastic syndromes The NCI PDQ patientstatement on myelodysplastic syndromes (or myelodysplasia). http://leukemia.acor.org/mpd.html

Search ACOR Site Contents: Types of Leukemia Living with Leukemia Transplants Survivor Stories Resources Contents Resources for Myelodysplasia or Myelodysplastic Syndromes Adult Myelodysplasia Patient Stories Childhood Myelodysplasia Patient Stories In Loving Memory of those who passed away from Myelodysplasia. Information on subscribing to the Aplastic Anemia and Myleodysplastic Syndrome support list (AA-MDS-Talk) mailing list Resources for Myelproliferative Disorders (MPD) Information on subscribing to the Myeloproliferative Disorders (MPD-Net) mailing list Information on subscribing to the BMT-Talk mailing list The Myelodysplastic Syndromes (MDS) MDS Include: Refractory Anemia Refractory Anemia with Sideroblasts Refractory Anemia with Excess Blasts Chronic Myelomonocytic Leukemia Refractory Anemia with Excess Blasts in Transformation Preleukemia including Aplastic Anemia caused by environmental exposure PH negative Chronic Myelocytic Leukemia Myelodysplastic Syndromes (MDS) Resources The NCI PDQ patient statement on Myelodysplastic Syndromes (or myelodysplasia).

48. University Of Florida Shands Cancer Center: Myelodysplastic Syndrome myelodysplastic syndromes are a group of diseases characterized by the body’s The myelodysplastic syndromes are really several different diseases, http://www.ufscc.ufl.edu/content.aspx?section=typesofcancer&id=842

49. University Of Florida Shands Cancer Center: Latest Cancer News Revlimid® Shows Promise for myelodysplastic syndromes (5/23/2005) Dacogen�Effective in myelodysplastic syndromes (4/27/2005) http://www.ufscc.ufl.edu/cancernews.aspx?section=cancernews&display=summary&cid=

50. Myelodysplastic Syndromes/Myeloproliferative Disorders Online health news and information for consumers. http://www.stayinginshape.com/3osfcorp/libv/i80.shtml

BROWSE FOR HEALTH INFORMATION BY TOPIC: HEART CANCER WOMEN MEN ... ALL TOPICS A - Z Myelodysplastic Syndromes/Myeloproliferative Disorders Myelodysplastic syndromes (MDS) and myeloproliferative disorders are diseases of the blood and bone marrow. The National Cancer Institute (NCI) says myelodysplastic syndromes are the result of not enough healthy blood cells being produced. Myeloproliferative disorders are the result of too many blood cells being produced. Myelodysplastic syndromes (MDS) The American Cancer Society (ACS) estimates that each year 10 to 15 thousand people are diagnosed with MDS. Most of them are over 60 years of age and more men than women are affected. MDS has not always been considered a cancer, according to ACS but is now being considered a form of cancer. ACS also says about 30 percent of MDS cases progress to become acute myeloid leukemia. (Read about " Leukemia ") NCI says basically the bone marrow does not make enough healthy blood cells. The key word there is healthy. Many of the cells that are created are abnormal. Normally, the bone marrow produces stem cells (immature cells) that develop into mature blood cells. There are 3 types of mature blood cells: Red blood cells that carry oxygen and other materials to all tissues of the body White blood cells that fight infection and disease (Read about "

51. Myelodysplastic Syndrome, Information, Seattle, Washington, What Is Myelodysplas Patients with myelodysplastic syndrome may also bleed without obvious reason, myelodysplastic syndromes Foundation www.mdsfoundation.org http://www.seattlecca.org/patientsandfamilies/adultCare/clinicalProgs/Myelodyspl

< Myelodysplastic Syndrome (MDS) var QUICKLINKS = '' + '' + 'Quick Links' + 'Appointments' + 'Clinical Trials' + 'Symptom Management' + 'Maps/Driving Directions' + 'Radiation Oncology Services' + '' if(document.layers) document.write(''); if(is.ns5) document.write(''); var OPENNODE = '1000,1004,1009,1010,3344,3355,'; var CURRNODE = 3355 Home Adult Care Clinical Services Myelodysplastic Syndrome (MDS) > Patient Education Choose a Diagnosis Autoimmune Diseases Bladder Cancer Blood Disorders Bone Marrow Transplant Breast Cancer Breast Cancer in Men Breast Health Cervical Cancer Colorectal Cancer Endometrial Cancer Gastrointestinal Cancer Prevention Gestational Trophoblastic Disease Gynecologic Cancers Kidney Cancer Leukemia Liver Cancer Lung Cancer Lymphoma Melanoma Mesothelioma Multiple Myeloma Myelodysplastic Synd. Ovarian Cancer Pancreatic Cancer Pediatric Cancer Pediatric Bone Marrow Transplant Prostate Cancer Sarcoma Skin Cancer Stomach Cancer Vulvar Cancer Myelodysplastic Syndrome (MDS) Patient Education What is Myelodysplastic Syndrome?

52. Mds04 CME Information MDS Presentations CME Information myelodysplastic syndromesDiagnosis and Emerging Therapies http://www.bloodline.net/mds04/

Bloodline Home About Call for Papers Free Membership ... Search Educational Features Image Atlas Case Studies Private Lectures Conference Reviews ... Glossary Resources Conference Calendar Hematology Links BMT Reviews Classifieds Specialties BMT/Stem Cell Cord Blood Thrombosis Hemostasis ... Veterinary News Hematology News Blood News Update Discussion Today's Discussion Create New Topic List by Topic Members Join Now Login CME Information MDS: Presentations ... Carden Jennings Publishing Co., Ltd. Featured Resources Frontiers in HematOncology Pharmacy Edition Volume 3, Issue 1 Online CME Understanding DNA Methylation and Epigenetic Gene Silencing in Cancer Online CME Myelodysplastic Syndromes: Diagnosis and Emerging Therapies Online CME Bloodline Reviews, Vol. 4, Issue 1 Prophylaxis and Pre-Emptive Therapy in Patients at Risk for CMV Disease After Stem Cell Transplant Blood and Marrow Transplantation Reviews Photoimmune Therapy: Extended Applications for GvHD Bloodline Reviews Volume 3, Issue 2 Immuno-fine-tuning: Focus on Intravenous Immune Globulin Selection Blood and Marrow Transplantation Reviews: The Impact of CMV in Stem Cell Transplantation BloodLine Image Atlas

53. Myelodysplastic Syndromes - Patient UK myelodysplastic syndromes Patient UK. A directory of UK health, disease, illnessand related medical websites that provide patient information. http://www.patient.co.uk/showdoc/40024635/

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people. Myelodysplastic Syndromes Group of acquired clonal disorders affecting the haemopoietic system involving a defect in an early progenitor cell and therefore MDS can affect many cells. Previously have been referred to as pre-leukaemias, smouldering leukaemias and refractory anaemias. In many forms of MDS there are chromosomal abnormalities particularly including deletions of chromosomes 5 and 7 and trisomy 8. Primary acquired sideroblastic anaemia caused by disruption in haem synthesis (associated with consumption of alcohol, isoniazid or pyrazinamide) in a particular form of MDS. Epidemiology Prevalence Risk Factors Presentation Investigations Blood film and FBC (useful to see results over time), all cases show anaemia either normocytic or macrocytic. Blood film characteristically shows dysplasia as erythrocytes with anisocytosis (varying sizes), poikilocytosis (abnormal shape) and basophilic stippling. Polymorphs are commonly hypolobulated and may show characteristic bilobed appearance. May also be hypogranulation and abnormal chromatin.

54. Stanford Cancer Center - Myelodysplastic Syndromes (MDS) | Cancer Types | Stanfo myelodysplastic syndromes (MDS) are a group of diseases that cause immature bloodcells (called blasts) to accumulate in the bone marrow leading to a http://cancer.stanfordhospital.com/cancerTypes/leukemias/MDS/default

Home For Patients For Health Professionals Students ... Leukemias Myelodysplastic Syndromes (MDS) Myelodysplastic syndromes (MDS) are a group of diseases that cause immature blood cells (called blasts) to accumulate in the bone marrow leading to a shortage of mature blood cells, including red blood cells, white blood cells, and platelets. Furthermore, the mature blood cells that are made can also be defective. MDS are not cancer themselves, but about 30% of the time the syndromes are a precursor to leukemias such as  acute myeloid leukemia (AML)  and  chrome myelomonocytic leukemia (CMML) Although MDS can affect people of all ages, the median age of onset is 65. MDS affects less than 15,000 people each year in the United States, and includes the following syndromes: 5q syndrome (named after the chromosomal defect that causes the symptoms) Hypoplastic MDS MDS with myelofibrosis MDS with prominent eosinophilia or monocytosis Causes of MDS People who have received radiation therapy, chemotherapy with alkylating agents (such as chlorambucil, cyclophosphamide, and melphalan), or who have been exposed to industrial solvents (such as benzene) have a higher risk of developing MDS than people who have not had these exposures. Rarely, genetic disorders are responsible for the disease. Nevertheless, in 60% to 70% of MDS patients, no specific cause can be identified. Stanford Expertise The Stanford MDS Center has been recognized by the MDS Foundation as an MDS Center of Excellence. In addition, physicians in the Center participate in developing national treatment guidelines, serve on the boards of MDS organizations, and are actively involved in clinical trials for MDS.

55. Myelodysplastic Syndromes A booklet, aimed at patients, about myelodysplastic syndromes. A collectionof resources on myelodysplastic syndromes including statistics, http://omni.ac.uk/browse/mesh/D009190.html

low graphics Myelodysplastic Syndromes broader: Bone Marrow Diseases other: Anemia, Aplastic Myeloproliferative Disorders narrower: Hemoglobinuria, Paroxysmal Leukemia, Myeloid Myelodysplastic syndromes A booklet, aimed at patients, about myelodysplastic syndromes. The booklet explains the types, causes, signs and symptoms, diagnosis, treatment, and prognosis of myelodysplastic syndromes (a group of diseases in which the production of blood cells is disrupted). Published on the Web by the Leukaemia Research Fund. Patient Education Handout [Publication Type] Myelodysplastic Syndromes Chronic myeloid leukaemia information centre Patient Education Handout [Publication Type] ... Myelodysplastic syndromes A collection of resources on myelodysplastic syndromes including statistics, and access to relevant guidelines, further reading, Medline searches, papers, trials, patient information, and other resources (including Web sites). The resources will be of interest to a professional and lay audience. Published on the Web by the Leukaemia Research Fund. Myelodysplastic Syndromes Myelodysplastic Syndromes Foundation The Myelodysplastic Syndromes Foundation (MSF) is a US based organisation established by an international group of physicians and researchers to provide an ongoing exchange of information relating to myelodysplastic syndromes (MDS). The site provides informatiion about the organisation, the causes of MDS, publications, an International Patient Registry, and links to sites of related interest. There is access to newsletters, The MDS News, full-text articles and selected abstracts from relevant journals. It has International Research Updates which contain details of current trials in the USA and Europe. A range of patient information resources are available in PDF, which requires Adobe Acrobat Reader. The site is aimed at patients, families, and physicians.

56. UpToDate Patient Information: Myelodysplastic Syndromes (MDS) The myelodysplastic syndromes (MDS, myelodysplasia) are not one specific disease, Clinical manifestations and diagnosis of the myelodysplastic syndromes http://patients.uptodate.com/topic.asp?file=blod_dis/6748

57. UpToDate Clinical Manifestations And Diagnosis Of The Myelodysplastic Syndromes INTRODUCTION — The myelodysplastic syndromes (MDS) comprise a heterogeneous groupof malignant stem cell disorders characterized by dysplastic and http://patients.uptodate.com/topic.asp?file=leukemia/14065

58. Rural Nurse Organization Clinic Digital Library Myelodysplastic Syndrome (MDS) Peripheral Blood Access document; MDS Bone MarrowAccess myelodysplastic syndromes Treatment Table of contents http://ruralnurseorganization-dl.slis.ua.edu/clinical/hematology/anemias/myelody

Clinical Resources by Topic: Hematology Myelodysplastic Syndrome Clinical Resources Pediatrics Geriatrics Pathology Clinical Guidelines ... Miscellaneous Resources See also: General Hematology Clinical Resources Myelodysplastic Syndrome Patient/Family Resources The Merck Manual 17th Ed.-1999: Table of contents Chapter 105: Leukemias: Table of contents General: Access document Myelodysplastic Syndrome: Access document Chapter 127: Anemias: Table of contents General: Access document Anemias Caused by Deficient Erythropoiesis: Access document Microcytic Anemias: Access document Introduction: Access document Iron-Utilization Anemias: Access document Medicine, Ob/Gyn, Psychiatry, and Surgery (eMedicine): Table of contents Myelodysplastic Syndrome: Access document Myelophthisic Anemia: Access document Pediatrics Resources See also General Pediatrics Resources Pediatrics (eMedicine): Table of contents Myelodysplastic Syndrome: Access document Myelodysplasia: Access document Geriatrics Resources See also General Geriatrics Resources Merck Manual of Geriatrics: Table of contents Chapter 73. Hematologic Malignancies:

59. MedlinePlus: Bone Marrow Diseases Overviews; What Are myelodysplastic syndromes and Statistics; What Are theKey Statistics about Myelodysplastic Syndrome? (American Cancer Society) http://www.nlm.nih.gov/medlineplus/bonemarrowdiseases.html

@import url(http://www.nlm.nih.gov/medlineplus/images/advanced.css); Skip navigation Other health topics: A B C D ... List of All Topics Bone Marrow Diseases Contents of this page: From the NIH Overviews Diagnosis/Symptoms Treatment ... Statistics Search MEDLINE/PubMed for recent research articles on Bone Marrow Diseases You may also be interested in these MedlinePlus related pages: Anemia Bone Marrow Transplantation Multiple Myeloma Blood/Lymphatic System From the National Institutes of Health Chronic Myeloproliferative Disorders (PDQ): Treatment (National Cancer Institute) Also available in: Spanish Myelodysplastic Syndromes (PDQ): Treatment (National Cancer Institute) Also available in: Spanish Myelodysplastic/Myeloproliferative Diseases (PDQ): Treatment (National Cancer Institute) Overviews What Are Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Diseases? (American Cancer Society) Diagnosis/Symptoms Platelet Count (American Association for Clinical Chemistry) Understanding Your Complete Blood Count (National Institutes of Health, Clinical Center) - Links to PDF Also available in: Spanish Treatment General Approach to Treatment of MDS (Myelodysplastic Syndrome) (American Cancer Society) Long Term and Late Effects of Treatment for Blood Cancers MedlinePlus: Bone Marrow Transplantation (National Library of Medicine) Also available in: Spanish Specific Conditions Amyloidosis (Mayo Foundation for Medical Education and Research) Detailed Guide: Myelodysplastic Syndrome (American Cancer Society)

60. Medifocus: Myelodysplastic Syndrome Guidebook myelodysplastic syndromes (MDS) are a group of myeloid stem cell disorders The MediFocus Guidebook on Myelodysplastic Syndrome contains information that http://www.medifocus.com/myelodysplastic-syndrome.php?a=a

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 3     41-60 of 102    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20